We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.54B
AUM Growth
-$135M
Cap. Flow
-$214M
Cap. Flow %
-13.95%
Top 10 Hldgs %
25.05%
Holding
1,512
New
379
Increased
290
Reduced
289
Closed
425

Sector Composition

Rank Sector Weight
1 Technology 14.1%
2 Consumer Discretionary 11.71%
3 Healthcare 9.05%
4 Industrials 8.79%
5 Financials 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPPI
976
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$45K ﹤0.01%
+46,889
New +$46.3K
LSB
977
DELISTED
LakeShore Biopharma
LSB
$44.4K ﹤0.01%
+3,220
New +$47.6K
SCRMW
978
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$44K ﹤0.01%
313,972
-203,270
-39% -$36.1K
ABUS icon
979
Arbutus Biopharma
ABUS
$915M
$43.2K ﹤0.01%
18,790
-12,409
-40% -$32.3K
GIFI
980
DELISTED
Gulf Island Fabrication
GIFI
$42.6K ﹤0.01%
+13,115
New +$44.4K
ILPT
981
Industrial Logistics Properties Trust
ILPT
$586M
$41.3K ﹤0.01%
+12,500
New +$27.9K
LYEL icon
982
Lyell Immunopharma
LYEL
$360M
$40.6K ﹤0.01%
638
-912
-59% -$50.5K
ERAS icon
983
Erasca
ERAS
$6.39B
$39.5K ﹤0.01%
+14,300
New +$40.7K
TMC icon
984
TMC The Metals Company
TMC
$1.98B
$37.7K ﹤0.01%
23,144
-4,812
-17% -$4.36K
QSI icon
985
Quantum-Si Incorporated
QSI
$177M
$37.5K ﹤0.01%
20,934
+1,587
+8% +$2.49K
CANO
986
DELISTED
Cano Health, Inc.
CANO
$36.9K ﹤0.01%
265
+142
+115% +$18.2K
FULC icon
987
Fulcrum Therapeutics
FULC
$297M
$36.9K ﹤0.01%
+11,171
New +$32.8K
NKTX icon
988
Nkarta
NKTX
$172M
$34.2K ﹤0.01%
+15,629
New +$68.7K
RXT icon
989
Rackspace Technology
RXT
$1.24B
$34K ﹤0.01%
12,501
-956
-7% -$1.58K
SRZN icon
990
Surrozen
SRZN
$301M
$33.9K ﹤0.01%
4,113
RBBN icon
991
Ribbon Communications
RBBN
$383M
$32.3K ﹤0.01%
11,566
-3,434
-23% -$9.53K
SLGC
992
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$31.8K ﹤0.01%
13,760
-42,133
-75% -$119K
VNET
993
VNET Group
VNET
$2.09B
$30.9K ﹤0.01%
10,653
-89,347
-89% -$272K
OSI.WS
994
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
$29.7K ﹤0.01%
275,000
BNR
995
Burning Rock Biotech
BNR
$92.9M
$29.2K ﹤0.01%
1,358
-5,210
-79% -$138K
TTCF
996
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$29.2K ﹤0.01%
53,423
+11,776
+28% +$12K
NBSE
997
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$29.1K ﹤0.01%
15,550
KPTI icon
998
Karyopharm Therapeutics
KPTI
$48M
$28.5K ﹤0.01%
1,062
-1,766
-62% -$76.1K
CVIIW
999
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$27.7K ﹤0.01%
198,010
+35,000
+21% +$4.26K
NGM
1000
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$27K ﹤0.01%
+10,416
New +$37.2K

Similar funds

Prelude Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Prelude Capital Management held 1,512 positions worth $1.54B, down 8.1% from $1.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Prelude Capital Management withdrew a net $214M in Q2 2023, closing 425 positions and reducing 289 holdings. Its most notable exit was Li Auto, an estimated $29.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Arconic Corporation worth $7.86M.

  • Prelude Capital Management's largest Q2 2023 buy was Arconic Corporation: 265,725 shares worth $7.86M.
  • Prelude Capital Management added most to IVERIC bio, Inc. Common Stock in Q2 2023, an estimated $10.9M increase.
  • Prelude Capital Management's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $65.4M.
  • Prelude Capital Management fully exited Li Auto in Q2 2023, selling an estimated $29.4M.
  • Prelude Capital Management's ten largest holdings make up 25% of its $1.54B portfolio in Q2 2023.
  • Prelude Capital Management opened 379 new positions and closed 425 in Q2 2023.
  • Prelude Capital Management's portfolio value fell 8.1% quarter-over-quarter to $1.54B.

Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.